Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|May 21, 2020
Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled TrialTor Olofsson, Johan K Wallman, Anna Jöud, et al.
Plos One|September 10, 2014
Accelerating translational research by clinically driven development of an informatics platform--a case studyImad Abugessaisa, Saedis Saevarsdottir, Giorgos Tsipras, et al.
Arthritis Research & Therapy|August 23, 2022
Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA studyLouise Hedenstierna, Anna Karin Hedström, Lars Klareskog, et al.
Rheumatology (Oxford, England)|November 12, 2020
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquineHeather Miller, Johan K Wallman, Ingemar F Petersson, et al.
Journal of Internal Medicine|April 7, 2025
Common genetic variants do not impact clinical prediction of methotrexate treatment outcomes in early rheumatoid arthritisAnton Öberg Sysojev, Bénédicte Delcoigne, Thomas Frisell, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate FailureKaren Hambardzumyan, Saedis Saevarsdottir, Kristina Forslind, et al.
Clinical and Experimental Rheumatology|April 6, 2021
Rheumatoid arthritis autoantibodies and their association with age and sexEleftheria Pertsinidou, Vivek Anand Manivel, Helga Westerlind, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 23, 2024
Minor Genetic Overlap Among Rheumatoid Arthritis, Myocardial Infarction, and Myocardial Infarction Risk DeterminantsAnton Öberg Sysojev, Lars Alfredsson, Lars Klareskog, et al.
Annals of the Rheumatic Diseases|September 21, 2011
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trialHamed Rezaei, Saedis Saevarsdottir, Kristina Forslind, et al.
Arthritis Research & Therapy|September 5, 2015
Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexateAase Haj Hensvold, Vijay Joshua, Wanying Li, et al.
Pageof 11